These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 10723070)
1. Broadly altered expression of the mRNA isoforms of FE65, a facilitator of beta amyloidogenesis, in Alzheimer cerebellum and other brain regions. Hu Q; Jin LW; Starbuck MY; Martin GM J Neurosci Res; 2000 Apr; 60(1):73-86. PubMed ID: 10723070 [TBL] [Abstract][Full Text] [Related]
2. Isoform-specific knockout of FE65 leads to impaired learning and memory. Wang B; Hu Q; Hearn MG; Shimizu K; Ware CB; Liggitt DH; Jin LW; Cool BH; Storm DR; Martin GM J Neurosci Res; 2004 Jan; 75(1):12-24. PubMed ID: 14689444 [TBL] [Abstract][Full Text] [Related]
3. Alternatively spliced isoforms of FE65 serve as neuron-specific and non-neuronal markers. Hu Q; Hearn MG; Jin LW; Bressler SL; Martin GM J Neurosci Res; 1999 Dec; 58(5):632-40. PubMed ID: 10561691 [TBL] [Abstract][Full Text] [Related]
4. Evidence for altered Numb isoform levels in Alzheimer's disease patients and a triple transgenic mouse model. Chigurupati S; Madan M; Okun E; Wei Z; Pattisapu JV; Mughal MR; Mattson MP; Chan SL J Alzheimers Dis; 2011; 24(2):349-61. PubMed ID: 21258150 [TBL] [Abstract][Full Text] [Related]
5. Expression of the Fe65 adapter protein in adult and developing mouse brain. Kesavapany S; Banner SJ; Lau KF; Shaw CE; Miller CC; Cooper JD; McLoughlin DM Neuroscience; 2002; 115(3):951-60. PubMed ID: 12435432 [TBL] [Abstract][Full Text] [Related]
6. Amyloid precursor protein gene isoforms in Alzheimer's disease and other neurodegenerative disorders. Panegyres PK; Zafiris-Toufexis K; Kakulas BA J Neurol Sci; 2000 Feb; 173(2):81-92. PubMed ID: 10675649 [TBL] [Abstract][Full Text] [Related]
7. Expression of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in Alzheimer's disease. Boutajangout A; Boom A; Leroy K; Brion JP FEBS Lett; 2004 Oct; 576(1-2):183-9. PubMed ID: 15474035 [TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-I and its receptor in the frontal cortex, hippocampus, and cerebellum of normal human and alzheimer disease brains. Jafferali S; Dumont Y; Sotty F; Robitaille Y; Quirion R; Kar S Synapse; 2000 Dec; 38(4):450-9. PubMed ID: 11044892 [TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of a neuronal enriched novel transcript encoding the previously described p60Fe65 isoform. Domingues SC; Henriques AG; Fardilha M; da Cruz E Silva EF; da Cruz E Silva OA J Neurochem; 2011 Dec; 119(5):1086-98. PubMed ID: 21824145 [TBL] [Abstract][Full Text] [Related]
10. FE65 regulates and interacts with the Bloom syndrome protein in dynamic nuclear spheres - potential relevance to Alzheimer's disease. Schrötter A; Mastalski T; Nensa FM; Neumann M; Loosse C; Pfeiffer K; Magraoui FE; Platta HW; Erdmann R; Theiss C; Uszkoreit J; Eisenacher M; Meyer HE; Marcus K; Müller T J Cell Sci; 2013 Jun; 126(Pt 11):2480-92. PubMed ID: 23572515 [TBL] [Abstract][Full Text] [Related]
11. A candidate molecular mechanism for the association of an intronic polymorphism of FE65 with resistance to very late onset dementia of the Alzheimer type. Hu Q; Cool BH; Wang B; Hearn MG; Martin GM Hum Mol Genet; 2002 Feb; 11(4):465-75. PubMed ID: 11854179 [TBL] [Abstract][Full Text] [Related]
13. Measurement of altered AβPP isoform expression in frontal cortex of patients with Alzheimer's disease by absolute quantification real-time PCR. Tharp WG; Lee YH; Greene SM; Vincellete E; Beach TG; Pratley RE J Alzheimers Dis; 2012; 29(2):449-57. PubMed ID: 22258516 [TBL] [Abstract][Full Text] [Related]
14. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology. Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the novel protein P9TLDR (temporal lobe down-regulated) with a brain-site-specific gene expression modality in Alzheimer's disease brain. Yokota T; Akatsu H; Miyauchi T; Heese K FEBS Lett; 2012 Dec; 586(24):4357-61. PubMed ID: 23159938 [TBL] [Abstract][Full Text] [Related]
16. Accumulation of a repulsive axonal guidance molecule RGMa in amyloid plaques: a possible hallmark of regenerative failure in Alzheimer's disease brains. Satoh J; Tabunoki H; Ishida T; Saito Y; Arima K Neuropathol Appl Neurobiol; 2013 Feb; 39(2):109-20. PubMed ID: 22582881 [TBL] [Abstract][Full Text] [Related]
17. Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms. Lee J; Fukumoto H; Orne J; Klucken J; Raju S; Vanderburg CR; Irizarry MC; Hyman BT; Ingelsson M Exp Neurol; 2005 Jul; 194(1):91-6. PubMed ID: 15899246 [TBL] [Abstract][Full Text] [Related]
18. RCAN1-1L is overexpressed in neurons of Alzheimer's disease patients. Harris CD; Ermak G; Davies KJ FEBS J; 2007 Apr; 274(7):1715-24. PubMed ID: 17331188 [TBL] [Abstract][Full Text] [Related]